Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T23:35:43.108Z Has data issue: false hasContentIssue false

Effectiveness of Fenilpiratsetam (Entrop) in the Treatment of Asthenia Patients

Published online by Cambridge University Press:  15 April 2020

B. Mykhaylov
Affiliation:
Psychotherapy, Kharkov medical academy of postgraduate education, Kharkov, Ukraine
B. Fedak
Affiliation:
Psychotherapy, Healthcare Utility «Regional Clinical Hospital – Centre of urgent medical care and accident medicine», Kharkov, Ukraine
O. Kudinova
Affiliation:
Psychotherapy, Kharkov medical academy of postgraduate education, Kharkov, Ukraine
O. Korshyak
Affiliation:
Psychotherapy, Kharkov medical academy of postgraduate education, Kharkov, Ukraine

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The study included 90 patients with a diagnosis of neurasthenia (F48.0) and postconcussional syndrome (F07.2).

The main group included 60 patients, control group – 30 patients. Patients main group received 100 mg of Entrop twice a day during 21 days. Patients control group, received Piracetam 100 mg at some time.

The maine group patients after treatment by Entrop were obtained authentically significant differences in such psychopathological symptoms: general weakness (p <0.05), fatigue (p <0, 05), irritability (p <0, 05), headache (p <0.05), difficulty falling asleep (p <0.05), anxiety (p <0.05), lack of vigor after sleep (p <0.05), uncertainty (p <0, 05).

The 21-day Entrop therapy is a distinct entropy significantly improve basic cognitive functions:

  1. - Improves functioning of verbal memory in the form of increasing the volume of direct memory and long term memory;

  2. - Improves the function of voluntary attention, increasing volumes of information processed, reduces the effects of exhaustion, improved speed settings;

  3. - Improving the quality of counting operations;

  4. - Reduced the severity of perceptual – gnostic disorders;

  5. - There is a general increase in cognitive efficiency.

Appointment of Entrop 100 mg 2 times a day for 21 days did not cause any effects of intolerance and overall tolerability.

Type
Article: 1588
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.